Christian Doppler Research Association (CDG)
This sponsor has funded 1 studies across 1 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 50368 | Planned | Multimodal response prediction to the 177Lu-PSMA radioligand therapy with metastatic prostate cancer | No | No |
PAS by Risk Management Plan (RMP) requirement
Christian Doppler Research Association (CDG)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Christian Doppler Research Association (CDG)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Christian Doppler Research Association (CDG)
1 Study countries specified are the following:
- Austria